Cellnovo Group SA, having announced that it is facing a delay in the large-scale commercial deployment of its new insulin infusion solution, needed to find additional financing. A release dated 26 March stated, ‘Within such context affecting its short- and medium-term financing, its operating English subsidiary, Cellnovo Limited, employing 92 staff and located in Bridgend, Wales, has obtained the appointment by a competent English court of two representatives of RSM Restructuring Advisory LLP as “administrators”. In the interest of Cellnovo Limited’s creditors and partners, they intend to continue contacts initiated with strategic partners and investors in order to protect the value of the assets.’
We’ll report further on customer support information when we have it. www.cellnovo.com
News items and features like this appear in the Desang Diabetes Magazine, our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it’s free, and you can easily unsubscribe should you wish to).
